Transcriptomic signature related to poor welfare of sport horses

por Foury, A., Mach, N., Ruet, A., Lansade, L., Moisan, M.-P.
Publicado 2023

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

por Hottinger, A F, Aissa, A B, Espeli, V, Squiban, D, Dunkel, N, Vargas, M I, Hundsberger, T, Mach, N, Schaller, K, Weber, D C, Bodmer, A, Dietrich, P-Y
Publicado 2014

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

por Hottinger, A F, Ben Aissa, A, Espeli, V, Squiban, D, Dunkel, N, Vargas, M I, Hundsberger, T, Mach, N, Schaller, K, Weber, D C, Bodmer, A, Dietrich, P-Y
Publicado 2018

LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA)

por Joerger, M., Metaxas, Y., Schmitt, A., Koeberle, D., Zaman, K., Betticher, D., Mach, N., Renner, C., Mark, M.T., Petrausch, U., Caspar, C.B., Britschgi, C., Taverna, C., Zenger, F., Mingrone, W., Schulz, J., Kopp, C., Hayoz, S., Stathis, A., von Moos, R.
Publicado 2020

1570P Outcome and prognostic factors of COVID-19 infection in cancer patients: Final results of SAKK 80/20

por Joerger, M., Metaxas, Y., Zaman, K., Michielin, O.A., Mach, N., Betticher, D., Schmitt, A.M., Cantoni, N., Caspar, C.B., Stettler, S., Malval, R., Pless, M., Britschgi, C., Renner, C., Koeberle, D., Schulz, J., Kopp, C., Hayoz, S., Stathis, A., von Moos, R.
Publicado 2021